Location History:
- Choisy le Roi, FR (2010 - 2017)
- Sevres, FR (2018)
Company Filing History:
4 out of 223 
2 out of 104 
Years Active: 2010-2018
Title: Michel Bremont: Innovator in Recombinant Virus Technology
Introduction
Michel Bremont is a notable inventor based in Choisy le Roi, France. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant viruses for use in vaccines and immune responses. With a total of 6 patents to his name, Bremont's work has the potential to impact public health and disease prevention.
Latest Patents
One of his latest patents is titled "Recombinant novirhabdovirus usable as an antigen vector." This invention relates to a recombinant novirhabdovirus that expresses a chimeric protein. The protein comprises the sequence of an antigen of interest, flanked at the N-terminus by a signal peptide and at the C-terminus by a polypeptide that includes at least one portion of the transmembrane domain of a rhabdovirus G protein. This recombinant novirhabdovirus can be particularly useful for inducing an immune response to the antigen of interest.
Another significant patent is the "cDNA construct of Salmonidae alphavirus." This invention concerns recombinant DNAs that include cDNA of genomic RNA of a Salmonidae alphavirus, preceded by a spacer sequence and under the control of a suitable promoter. These recombinant DNAs are valuable for obtaining expression vectors, producing recombinant Salmonidae alphavirus, and developing vaccines.
Career Highlights
Throughout his career, Michel Bremont has worked with esteemed organizations such as the Institut National de la Recherche Agronomique and Intervet International B.V. His experience in these institutions has allowed him to collaborate on various innovative projects that advance the field of biotechnology.
Collaborations
Some of his notable coworkers include Coralie Moriette and Stephane Villoing. Their collaborative efforts have contributed to the success of his research and patent developments.
Conclusion
Michel Bremont's innovative work in recombinant virus technology showcases his dedication to advancing biotechnology. His patents reflect a commitment to developing solutions that can enhance immune responses and contribute to vaccine development. His contributions are significant in the ongoing efforts to improve public health through scientific innovation.